Histone deacetlyase inhibitors are a new type of myeloma treatment currently in clinical trial. Dr Charlotte Pawlyn explains how these inhibitors work and how they are likely to be given to patients.
Histone deacetlyase inhibitors are a new type of myeloma treatment currently in clinical trial. Dr Charlotte Pawlyn explains how these inhibitors work and how they are likely to be given to patients.
